supp.fit

Coptis: study protocols

6 study groups say how much Coptis participants took a day. These are the doses the studies gave. They are not a recommendation.

Coptis: what the research found →

Dose per serving from research

6 study groups in 1 study say how much Coptis participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 g to 50 g, 83% of 6 study groups.

Daily doseStudy groups
10 g or less
1
10 g to 25 g
0
25 g to 50 g
5

Commonly used together

6 of 6 study groups took Coptis with something else, but nothing that 3 or more different studies gave.

6 study groups

Study
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 3 low-dose (LD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
9 g12 weeks36
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 3 medium-dose (MD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
27 g12 weeks36
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 2 low-dose (LD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
27 g12 weeks35
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 3 high-dose (HD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
45 g12 weeks34
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 2 high-dose (HD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
27 g12 weeks32
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
2024 · Study 2 medium-dose (MD) group · Adults aged 30–65 with newly diagnosed type 2 diabetes and dampness-heat syndrome
27 g12 weeks30